Pyruvate kinase M2 and prednisolone resistance in acute lymphoblastic leukemia

Treatment of childhood acute lymphoblastic leukemia (ALL) combines different classes of chemotherapeutic agents, such as Vinca alkaloids, anthracyclines and glucocorticoids (GCs). Although such therapy nowadays cures the majority of the patients, combination chemotherapy still fails in approximately

[1]  W. Evans,et al.  Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. , 2009, Blood.

[2]  M. Cazzola,et al.  Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis , 2009, Journal of internal medicine.

[3]  Ru Wei,et al.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.

[4]  N. Agarwal,et al.  Familial Polycythemia Caused by a Novel Mutation in the Beta Globin Gene: Essential Role of P50 in Evaluation of Familial Polycythemia , 2007, International journal of medical sciences.

[5]  Chi V Dang,et al.  Cancer's molecular sweet tooth and the Warburg effect. , 2006, Cancer research.

[6]  C. Boschek,et al.  Pyruvate kinase type M2 and its role in tumor growth and spreading. , 2005, Seminars in cancer biology.

[7]  A. Mesecar,et al.  Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. , 2005, Biochemistry.

[8]  H. Wajcman,et al.  Hemoglobins With High Oxygen Affinity Leading to Erythrocytosis. New Variants and New Concepts , 2005, Hemoglobin.

[9]  S. J. Darnton,et al.  The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia–dysplasia–adenocarcinoma sequence in Barrett’s oesophagus , 2004, Journal of Clinical Pathology.

[10]  M. D. Boer,et al.  Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  M. McMullin,et al.  Chuvash-type congenital polycythemia in 4 families of Asian and Western European ancestry. , 2003, Blood.

[12]  J. Hoyer,et al.  Three New Hemoglobin Variants with Abnormal Oxygen Affinity: Hb Saratoga Springs [α40(C5)Lys→Asn (α1)], Hb Santa Clara [β97(FG4)His→Asn], and Hb Sparta [β103(G5)Phe→Val] , 2003 .

[13]  S. Brennan,et al.  Haemoglobin Pierre-Benite--a high affinity variant associated with relative polycythaemia. , 2001, Clinical and laboratory haematology.

[14]  R. Pieters,et al.  Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs. , 1998, Blood.

[15]  S. Edelstein,et al.  Self-association of haemoglobin Olympia (alpha 2 beta 2 20 (B2) Val----Met). A human haemoglobin bearing a substitution at the surface of the molecule. , 1986, Journal of molecular biology.

[16]  H. Lehmann,et al.  Familial Polycythaemia Caused by a New Haemoglobin Variant: Hb Heathrow, β 103 (G5) Phenylalanine Leucine , 1973 .

[17]  J. Adamson,et al.  Hemoglobin olympia ( 20 valine leads to methionine): an electrophoretically silent variant associated with high oxygen affinity and erythrocytosis. , 1973, The Journal of clinical investigation.

[18]  F. Storti.  Ferrata Storti Foundation , 2008 .

[19]  G. Min-oo,et al.  Familial erythrocytosis: molecular links to red blood cell control , 2008 .

[20]  J. Hoyer,et al.  Three new hemoglobin variants with abnormal oxygen affinity: Hb Saratoga Springs [alpha40(C5)Lys --> Asn (alpha1)], Hb Santa Clara [beta97(FG4)His --> Asn], and Hb Sparta [beta103(G5)Phe --> Val]. , 2003, Hemoglobin.

[21]  R. Pieters,et al.  Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia. , 1997, Critical reviews in oncology/hematology.

[22]  R. Pieters,et al.  In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. , 1990, Blood.

[23]  A. Francina,et al.  Hehemoglobin Pierre-Bénite [β90(F6)Glu→Asp], a new High Affinity Variant Found in a French Family , 1988 .

[24]  H. Lehmann,et al.  Familial polycythaemia caused by a new haemoglobin variant: Hb Heathrow, beta 103 (G5) phenylalanine leads to leucine. , 1973, British medical journal.

[25]  G. Paolucci,et al.  [Treatment of acute lymphoblastic leukemia]. , 1971, Minerva pediatrica.